A Screening Study to Detect BRAF V600 Mutation-Positive Patients For Enrollment Into Clinical Research Studies of Zelboraf (Vemurafenib)
Public ClinicalTrials.gov record NCT01804140. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Screening Protocol to Detect BRAF V600 Mutation-Positive Patients for Enrollment Into Clinical Research Studies of Vemurafenib
Study identification
- NCT ID
- NCT01804140
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Genentech, Inc.
- Industry
- Enrollment
- 662 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2012
- Primary completion
- Aug 31, 2013
- Completion
- Aug 31, 2013
- Last update posted
- Nov 1, 2016
2012 – 2013
United States locations
- U.S. sites
- 20
- U.S. states
- 10
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Sedona | Arizona | 86336 | — |
| Not listed | Tucson | Arizona | 85704 | — |
| Not listed | Burbank | California | 91505 | — |
| Not listed | Rancho Cucamonga | California | 91730 | — |
| Not listed | Denver | Colorado | 80218 | — |
| Not listed | Ocala | Florida | 34471 | — |
| Not listed | Woodbury | Minnesota | 55125 | — |
| Not listed | Columbia | Missouri | 65201 | — |
| Not listed | Las Vegas | Nevada | 89169 | — |
| Not listed | Nashville | Tennessee | 37232 | — |
| Not listed | Amarillo | Texas | 79106 | — |
| Not listed | Austin | Texas | 78705 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | Dallas | Texas | 75237 | — |
| Not listed | Dallas | Texas | 75246 | — |
| Not listed | Denton | Texas | 76210 | — |
| Not listed | McAllen | Texas | 78503 | — |
| Not listed | Tyler | Texas | 75702 | — |
| Not listed | Spokane | Washington | 99204 | — |
| Not listed | Yakima | Washington | 98902 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01804140, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 1, 2016 · Synced May 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01804140 live on ClinicalTrials.gov.